The efficacy of low doses of radiotherapy for the treatment of pituitary corticotroph macrotumors in dogs is evaluated retrospectively. Twelve dogs with pituitary-dependent hyperadrenocorticism and a large pituitary tumor treated with 36 Gy of radiation were included. Radiation was delivered in 12 fractions of 3 Gy over a 4- to 6-week period. Effects of radiation therapy on tumor size were assessed by computed tomography scans; a decrease was observed in 11 dogs (decrease > 50% in 6 dogs). Three dogs were reirradiated due to major tumor regrowth or a lack of tumor decrease (mean total dose: 22 Gy given in 3-Gy fractions over 3 or 4 weeks). The mean and median survival times following the initiation of radiotherapy were 22.6 months (688 days) and 17.7 months (539 days), respectively. These data are consistent with previous findings, based on high-dose radiation, showing that radiotherapy is a useful option for treating pituitary corticotroph macrotumors in dogs. Furthermore, computed tomography follow-up of the treated dogs demonstrates objectively the efficacy of radiotherapy against corticotroph tumors in dogs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852601 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Clinical Characteristics, and Prevalence of Hepatic and Bone Mineral Density Abnormalities in Patients with Sheehan Syndrome: Data from a Tertiary Care Centre.
Endocr Pract
December 2024
Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
Objective: Sheehan syndrome (SS), or postpartum pituitary necrosis occurs due to reduced vascular supply following postpartum hemorrhage, often linked to coagulation abnormalities, and pituitary antibodies. A smaller sella turcica volume is a risk factor for SS, consequent to compressive effects on the pituitary stalk. Hypopituitarism in SS increases the risk of metabolic liver and bone diseases.
View Article and Find Full Text PDFUsing digital PCR to investigate the prevalence of KRAS variants in pituitary tumours.
J Neuroendocrinol
December 2024
Laboratório de Biomedicina do Cérebro, Instituto Estadual do Cérebro Paulo Niemeyer, Secretaria Estadual de Saúde, Rio de Janeiro, Brazil.
Pituitary tumours (PT) are formed in the pituitary gland, a small gland situated at the base of the brain. These tumours can be categorized according to their histological origin and hormone production. In surgical series, non-functioning PT are the commonest subtype, followed by functioning somatotroph and corticotroph tumours.
View Article and Find Full Text PDFEvidence for the contribution of vasopressin V1 receptors in the pathophysiology of depression.
Biochem Pharmacol
January 2025
Department of Trauma Center, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China. Electronic address:
Depression is a chronic and recurrent psychiatric condition characterised by depressed mood, loss of interest or pleasure, poor sleep, low appetite, and poor concentration. Research has shown that both heritable and environmental risk factors are involved in the pathogenesis of depression. In addition, several studies have indicated that dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is implicated in the development of depression in adulthood.
View Article and Find Full Text PDFModeling corticotroph deficiency with pituitary organoids supports the functional role of in human pituitary differentiation.
Elife
November 2024
Aix-Marseille University, INSERM, UMR1251, Marseille Medical Genetics, Institut MarMaRa, Marseille, France.
Article Synopsis
- Deficient Anterior pituitary with common Variable Immune Deficiency (DAVID) syndrome is caused by heterozygous mutations leading to adrenocorticotropic hormone deficiency and immune system issues.
- Researchers created pituitary organoids from edited human stem cells to study how specific genetic mutations affect pituitary development and found that these mutations significantly reduced the number of hormone-producing cells called corticotrophs.
- The study identified changes in gene expression related to pituitary development and suggested that the observed mutations have a direct impact on endocrine function, classifying them as pathogenic for pituitary development.
Diagnostic challenges in pediatric Cushing's disease associated with chronic renal failure: a report of three patients.
J Pediatr Endocrinol Metab
November 2024
Department of Endocrinology, Hospital de Pediatría J.P. Garrahan, Buenos Aires, Argentina.
Article Synopsis
- Cushing's disease (CD) co-occurring with chronic kidney disease (CKD) is rare and makes diagnosis challenging due to CKD-induced hypercortisolism; this report presents three female cases to improve understanding of diagnosis in such contexts.
- Each patient, aged between 12 and 16, had various CKD-related conditions and presented symptoms typical of CD, which were confirmed through clinical and biochemical evaluations; surgical interventions led to remission, but some patients developed pituitary deficiencies.
- These cases highlight the need for careful clinical assessment in diagnosing CD among CKD patients, as clear diagnostic criteria are currently lacking.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!